Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Replacement of the Native Mitral Valve Using the ReValve System

NCT: NCT07601269 · RECRUITING

NCT IDNCT07601269
StatusRECRUITING
Start Date2026-04-26
Completion2028-04

Brief Summary

This study is to collect preliminary chronic information on performance and safety of the ReValve System.

Frequently Asked Questions

What is Replacement of the Native Mitral Valve Using the ReValve System?

Replacement of the Native Mitral Valve Using the ReValve System is a clinical trial registered under NCT07601269. Current status: RECRUITING.

What is the status of NCT07601269?

The current status of NCT07601269 (Replacement of the Native Mitral Valve Using the ReValve System) is: RECRUITING.

When did Replacement of the Native Mitral Valve Using the ReValve System start?

Replacement of the Native Mitral Valve Using the ReValve System started on 2026-04-26.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑